304 related articles for article (PubMed ID: 35747820)
1. Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors.
Crabtree JS
Front Oncol; 2022; 12():901435. PubMed ID: 35747820
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective.
Finnerty BM; Gray KD; Moore MD; Zarnegar R; Fahey Iii TJ
World J Gastrointest Oncol; 2017 Sep; 9(9):341-353. PubMed ID: 28979716
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Epigenome in Gastroenteropancreatic Neuroendocrine Neoplasias.
Sharma R; Lythgoe MP; Slaich B; Patel N
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439335
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine tumours: cracking the epigenetic code.
Karpathakis A; Dibra H; Thirlwell C
Endocr Relat Cancer; 2013 Jun; 20(3):R65-82. PubMed ID: 23429748
[TBL] [Abstract][Full Text] [Related]
5. DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors.
Rahman MM; Qian ZR; Wang EL; Yoshimoto K; Nakasono M; Sultana R; Yoshida T; Hayashi T; Haba R; Ishida M; Okabe H; Sano T
Hum Pathol; 2010 Aug; 41(8):1069-78. PubMed ID: 20381114
[TBL] [Abstract][Full Text] [Related]
6. Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms.
Mafficini A; Scarpa A
Endocr Rev; 2019 Apr; 40(2):506-536. PubMed ID: 30657883
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic alterations in pancreatic neuroendocrine tumors.
Tirosh A; Kebebew E
J Gastrointest Oncol; 2020 Jun; 11(3):567-577. PubMed ID: 32655936
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
9. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.
Asa SL; La Rosa S; Basturk O; Adsay V; Minnetti M; Grossman AB
Endocr Pathol; 2021 Mar; 32(1):169-191. PubMed ID: 33459926
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumors.
Dreijerink KM; Hackeng WM; Singhi AD; Heaphy CM; Brosens LA
J Pathol; 2022 Feb; 256(2):143-148. PubMed ID: 34750813
[TBL] [Abstract][Full Text] [Related]
11. [Genetic profile of gastroenteropancreatic neuroendocrine tumors].
Cabezas Agrícola JM
Endocrinol Nutr; 2009 Apr; 56 Suppl 2():16-9. PubMed ID: 19627765
[TBL] [Abstract][Full Text] [Related]
12. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms.
Canakis A; Lee LS
World J Gastrointest Endosc; 2022 May; 14(5):267-290. PubMed ID: 35719897
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors.
Larsson C
Neuroendocrinology; 2013; 97(1):19-25. PubMed ID: 22456267
[TBL] [Abstract][Full Text] [Related]
14. Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer.
Maruyama R; Suzuki H; Yamamoto E; Imai K; Shinomura Y
Tumour Biol; 2012 Apr; 33(2):277-85. PubMed ID: 22219034
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors.
How-Kit A; Dejeux E; Dousset B; Renault V; Baudry M; Terris B; Tost J
Epigenomics; 2015; 7(8):1245-58. PubMed ID: 26360914
[TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic drivers of neuroendocrine tumours (NET).
Di Domenico A; Wiedmer T; Marinoni I; Perren A
Endocr Relat Cancer; 2017 Sep; 24(9):R315-R334. PubMed ID: 28710117
[TBL] [Abstract][Full Text] [Related]
17. [Epigenetics' implication in autism spectrum disorders: A review].
Hamza M; Halayem S; Mrad R; Bourgou S; Charfi F; Belhadj A
Encephale; 2017 Aug; 43(4):374-381. PubMed ID: 27692350
[TBL] [Abstract][Full Text] [Related]
18. Epigenomics in cancer management.
Costa FF
Cancer Manag Res; 2010 Oct; 2():255-65. PubMed ID: 21188117
[TBL] [Abstract][Full Text] [Related]
19. Analysis of molecular pathways in neuroendocrine cancers of the gastroenteropancreatic system.
Arnold CN; Sosnowski A; Blum HE
Ann N Y Acad Sci; 2004 Apr; 1014():218-9. PubMed ID: 15153437
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic Features of Gastroenteropancreatic Neuroendocrine Tumors: A Single-center Experience.
Akın Telli T; Esin E; Yalçın Ş
Balkan Med J; 2020 Aug; 37(5):281-286. PubMed ID: 32573179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
